Pilar Hernández Con

Pilar Hernández Con,

GRADUATE AST-G

Department: Pharmaceutical Outcomes & Policy
Business Phone: (352) 273-5526
Business Email: hernandezcon.mpi@ufl.edu

About Pilar Hernández Con

Pilar Hernández Con, MD, MSCE is a graduate assistant and a fourth-year PhD student in the Department of Pharmaceutical Outcomes and Policy, University of Florida. She received her M.D. degree from the Universidad de Costa Rica and her MSCE from the University of Pennsylvania. She practiced as a primary care physician for six years in her native country (Costa Rica) before starting her training in epidemiology / pharmacoepidemiology. Pilar’s research interest lies in the intersection between pharmacoepidemiology and health services research, in a broad range of disease areas including Parkinson’s disease, HCV infection and NAFLD.

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0003-4959-9141

Publications

2023
Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States
Preventive Medicine Reports. 32 [DOI] 10.1016/j.pmedr.2023.102138. [PMID] 36865395.
2023
Course of Impulse Control Disorder Symptoms in Parkinson’s Disease: Deep Brain Stimulation Versus Medications
Movement Disorders Clinical Practice. 10(6):903-913 [DOI] 10.1002/mdc3.13738. [PMID] 37332637.
2023
Dopamine agonists and risk of lung cancer in patients with restless legs syndrome
Pharmacoepidemiology and Drug Safety. 32(7):726-734 [DOI] 10.1002/pds.5596.
2023
Hepatitis C Cascade of Care in the Direct-Acting Antivirals Era: A Meta-Analysis
American Journal of Preventive Medicine. [DOI] 10.1016/j.amepre.2023.06.016.
2023
Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States
Journal of Managed Care & Specialty Pharmacy. 29(7):721-731 [DOI] 10.18553/jmcp.2023.29.7.721. [PMID] 37404074.
2019
AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity.
Molecular therapy : the journal of the American Society of Gene Therapy. 27(2):465-478 [DOI] 10.1016/j.ymthe.2018.11.013. [PMID] 30559071.
2019
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
JAMA neurology. 76(3):318-325 [DOI] 10.1001/jamaneurol.2018.3746. [PMID] 30508027.
2019
Characterization of Parkinson’s disease using blood-based biomarkers: A multicohort proteomic analysis
PLOS Medicine. 16(10) [DOI] 10.1371/journal.pmed.1002931. [PMID] 31603904.
2017
Cognitive behavioral therapy for insomnia in Parkinson’s disease: a case series.
NPJ Parkinson's disease. 3 [DOI] 10.1038/s41531-017-0027-z. [PMID] 28765835.

Education

PhD
2020-2024 · University of Florida
MSCE
2018-2021 · University of Pennsylvania
MD
2006 · Universidad de Costa Rica

Contact Details

Phones:
Business:
(352) 273-5526
Emails:
Addresses:
Business Mailing:
PO Box 100496
GAINESVILLE FL 32611
Business Street:
1889 Museum Road
GAINESVILLE FL 32611